| Dr Yuyao Zhang, MD | |
|
1304 Fawcett Ave Ste 100, Tacoma, WA 98402 | |
| (253) 761-4201 | |
| (253) 761-4201 |
| Full Name | Dr Yuyao Zhang |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 12 Years |
| Location | 1304 Fawcett Ave Ste 100, Tacoma, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003182999 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD60866076 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health - Fairfield Hospital | Fairfield, OH | Hospital |
| Mercy Health - Clermont Hospital | Batavia, OH | Hospital |
| Mercy Health - West Hospital | Cincinnati, OH | Hospital |
| Mercy Health-anderson Hospital | Cincinnati, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbus Radiology Corp | 6507754983 | 271 |
News Archive
Devastating blood-borne fungal infections that can be lethal for HIV/AIDS, cancer, and organ transplant patients may be treated more successfully, thanks to a new drug delivery method developed by researchers at the University of British Columbia in Vancouver.
A new study identified an adenovirus gene therapy vector carrying a VEGF isoform. It can improve uterine blood flow in placental insufficiency, as reported in the peer-reviewed journal Human Gene Therapy.
Blueprint Medicines today announced that the Journal of Clinical Investigation published an overview of the Company's kinase drug discovery and development strategy. The publication underscores Blueprint Medicines' focus on identifying novel genomically defined disease drivers and the use of novel chemistry from its proprietary compound library to craft highly selective kinase inhibitors for new and difficult-to-drug kinase targets.
Levels of carbonic anhydrase 9 increase with the use of vascular endothelial growth factor-targeted therapy for metastatic clear-cell renal cancer, and high expression of this protein is associated with increased survival, show study results reported in European Urology.
One of the tiniest entities in the human genome - are great escape artists.
› Verified 1 days ago
| Entity Name | Columbus Radiology Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669408159 PECOS PAC ID: 6507754983 Enrollment ID: O20040308000742 |
News Archive
Devastating blood-borne fungal infections that can be lethal for HIV/AIDS, cancer, and organ transplant patients may be treated more successfully, thanks to a new drug delivery method developed by researchers at the University of British Columbia in Vancouver.
A new study identified an adenovirus gene therapy vector carrying a VEGF isoform. It can improve uterine blood flow in placental insufficiency, as reported in the peer-reviewed journal Human Gene Therapy.
Blueprint Medicines today announced that the Journal of Clinical Investigation published an overview of the Company's kinase drug discovery and development strategy. The publication underscores Blueprint Medicines' focus on identifying novel genomically defined disease drivers and the use of novel chemistry from its proprietary compound library to craft highly selective kinase inhibitors for new and difficult-to-drug kinase targets.
Levels of carbonic anhydrase 9 increase with the use of vascular endothelial growth factor-targeted therapy for metastatic clear-cell renal cancer, and high expression of this protein is associated with increased survival, show study results reported in European Urology.
One of the tiniest entities in the human genome - are great escape artists.
› Verified 1 days ago
| Entity Name | Bsmh Cincinnati Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225797426 PECOS PAC ID: 1850774167 Enrollment ID: O20220819000827 |
News Archive
Devastating blood-borne fungal infections that can be lethal for HIV/AIDS, cancer, and organ transplant patients may be treated more successfully, thanks to a new drug delivery method developed by researchers at the University of British Columbia in Vancouver.
A new study identified an adenovirus gene therapy vector carrying a VEGF isoform. It can improve uterine blood flow in placental insufficiency, as reported in the peer-reviewed journal Human Gene Therapy.
Blueprint Medicines today announced that the Journal of Clinical Investigation published an overview of the Company's kinase drug discovery and development strategy. The publication underscores Blueprint Medicines' focus on identifying novel genomically defined disease drivers and the use of novel chemistry from its proprietary compound library to craft highly selective kinase inhibitors for new and difficult-to-drug kinase targets.
Levels of carbonic anhydrase 9 increase with the use of vascular endothelial growth factor-targeted therapy for metastatic clear-cell renal cancer, and high expression of this protein is associated with increased survival, show study results reported in European Urology.
One of the tiniest entities in the human genome - are great escape artists.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yuyao Zhang, MD 1304 Fawcett Ave Ste 100, Tacoma, WA 98402-1900 Ph: (253) 761-4201 | Dr Yuyao Zhang, MD 1304 Fawcett Ave Ste 100, Tacoma, WA 98402 Ph: (253) 761-4201 |
News Archive
Devastating blood-borne fungal infections that can be lethal for HIV/AIDS, cancer, and organ transplant patients may be treated more successfully, thanks to a new drug delivery method developed by researchers at the University of British Columbia in Vancouver.
A new study identified an adenovirus gene therapy vector carrying a VEGF isoform. It can improve uterine blood flow in placental insufficiency, as reported in the peer-reviewed journal Human Gene Therapy.
Blueprint Medicines today announced that the Journal of Clinical Investigation published an overview of the Company's kinase drug discovery and development strategy. The publication underscores Blueprint Medicines' focus on identifying novel genomically defined disease drivers and the use of novel chemistry from its proprietary compound library to craft highly selective kinase inhibitors for new and difficult-to-drug kinase targets.
Levels of carbonic anhydrase 9 increase with the use of vascular endothelial growth factor-targeted therapy for metastatic clear-cell renal cancer, and high expression of this protein is associated with increased survival, show study results reported in European Urology.
One of the tiniest entities in the human genome - are great escape artists.
› Verified 1 days ago
Mark Ranier Dalisay, Radiology Medicare: Not Enrolled in Medicare Practice Location: 7520 S I St, Tacoma, WA 98408 Phone: 702-305-1889 | |
Dr. Joel Thomas Mcfarland, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 Fax: 253-596-3301 | |
Dr. Jana Lynn Fahmy, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1304 Fawcett Ave Ste 100, Tacoma, WA 98402 Phone: 253-761-4200 Fax: 253-761-4201 | |
Dr. Scott Randall Henneman, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1304 Fawcett Ave Ste 100, Tacoma, WA 98402 Phone: 253-761-4200 Fax: 253-761-4201 | |
Dr. Mark Gerard O'callaghan, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 | |
Peter Alan Ory, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1304 Fawcett Ave, Suite 100, Tacoma, WA 98402 Phone: 253-680-3372 Fax: 253-383-3553 |